BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33023313)

  • 1. miR-19 Promotes Cell Proliferation, Invasion, Migration, and EMT by Inhibiting SPRED2-mediated Autophagy in Osteosarcoma Cells.
    Xie C; Liu S; Wu B; Zhao Y; Chen B; Guo J; Qiu S; Cao YM
    Cell Transplant; 2020; 29():963689720962460. PubMed ID: 33023313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1.
    Zhao X; Xu Y; Sun X; Ma Y; Zhang Y; Wang Y; Guan H; Jia Z; Li Y; Wang Y
    J Cell Biochem; 2019 Apr; 120(4):5495-5504. PubMed ID: 30302813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-218 promotes oxidative stress and inflammatory response by inhibiting SPRED2-mediated autophagy in HG-induced HK-2 cells.
    Fu L; Huang X; Zhang J; Lin Z; Qin G
    Adv Clin Exp Med; 2022 Sep; 31(9):1011-1022. PubMed ID: 35506187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
    Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W
    Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
    Fu Y; Tang Y; Wang J; Guo Z
    Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
    Bi W; Yang M; Xing P; Huang T
    Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
    Shi Y; Huang J; Zhou J; Liu Y; Fu X; Li Y; Yin G; Wen J
    Oncol Rep; 2015 Jul; 34(1):399-406. PubMed ID: 25998694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spred2 inhibits epithelial‑mesenchymal transition of colorectal cancer cells by impairing ERK signaling.
    Wang H; Liu S; Kong F; Xiao F; Li Y; Wang H; Zhang S; Huang D; Wang L; Yang Y
    Oncol Rep; 2020 Jul; 44(1):174-184. PubMed ID: 32319644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma.
    Wang X; Zhang L; Zhang X; Xing C; Liu R; Zhang F
    Cancer Biomark; 2020; 29(2):291-298. PubMed ID: 32675397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2.
    Liu X; Liang Z; Gao K; Li H; Zhao G; Wang S; Fang J
    Tumour Biol; 2016 Jun; 37(6):7951-7. PubMed ID: 26700675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-765 targets MTUS1 to promote the progression of osteosarcoma via mediating ERK/EMT pathway.
    Lv DB; Zhang JY; Gao K; Yu ZH; Sheng WC; Yang G; Gao YZ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4618-4628. PubMed ID: 31210288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
    Tan Y; Chen L; Li S; Hao H; Zhang D
    Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3.
    Qiu J; Zhang Y; Chen H; Guo Z
    Int J Oncol; 2018 Oct; 53(4):1493-1504. PubMed ID: 30015825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.